glp-1 drug for weight loss Another Weight-Loss Trial Win Weekly New GLP-1 Pill Foundayo (Orforglipron)

Commercial availability would likely follow in early 2027, pending approval and standard launch timelines

Weight loss medications like glucagon-like peptide-1 receptor agonists, or GLP-1s which include Wegovy (pill and pen), Zepbound , Foundayo , and Saxenda have gotten a lot of attention recently for their ability to help people lose significant amounts of weight and keep it off

Curr Pharm Des (2021)

Potential Role in Early Type 1 (Autoimmune) Diabetes A few weeks ago Dandong and colleagues published a series of 10 patients with recent diagnosis of autoimmune diabetes (with autoantibody assays), a HbA1c level of 11.7% and fasting C-peptide (reflecting insulin production) of 0.65 ng/ml

You are not trying to lose weight during the break